The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus
Xiaofang Dan,1- 3 Ke Li,1- 3 Jiali Xu,4 Pijun Yan1- 3,5,6 1Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China; 2Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, People's Republic of C...
Saved in:
Main Authors: | Dan X (Author), Li K (Author), Xu J (Author), Yan P (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuregulin-1, a potential therapeutic target for cardiac repair
by: Yan Wang, et al.
Published: (2022) -
Exercise Training, Neuregulin 4 and Obesity
by: Seyed Morteza Tayebi, et al.
Published: (2017) -
Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022) -
Association of Neuregulin Levels and Neuregulin-1 Polymorphism with Short-term Morbidities in Preterm Neonates
by: Bugis Lubis, et al.
Published: (2021) -
Neuregulins Response to Exercise: a Mini Review
by: Abbass Ghanbari-Niaki
Published: (2016)